Clinical Trials Browser

Phase 1 × Desipramine × Tumor-Agnostic × Clear all

NCT01358968 2018-10-25

A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine

Phase 1 Completed

20 enrolled 14 charts

Neoplasms